WallStreetZenWallStreetZen

NASDAQ: ANIX
Anixa Biosciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Anixa Biosciences revenue was $0.00 for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Jan 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Oct 31, 2024, ANIX annual revenue was $0.0, with -100% growth year-over-year.

ANIX past revenue growth

How has ANIX's revenue growth performed historically?

Company
-100%
Industry
511.06%
Market
20.87%
ANIX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANIX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANIX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANIX revenue history

Current Revenue
$0.0
Current Earnings
-$12.5M
Current Profit Margin
0%

Be the first to know when ANIX announces revenue.

ANIX Revenue History By Year

ANIX Yearly RevenueANIX RevenueANIX ChangeANIX Revenue Growth
2024-10-31$0.00-$210.00k-100.00%
2023-10-31$210.00kN/AN/A
2022-10-31$0.00-$512.00k-100.00%
2021-10-31$512.00kN/AN/A
2020-10-31$0.00-$250.00k-100.00%
2019-10-31$250.00k-$862.50k-77.53%
2018-10-31$1.11M$750.00k+206.90%
2017-10-31$362.50k$62.50k+20.83%
2016-10-31$300.00k-$8.96M-96.76%
2015-10-31$9.26M$5.59M+152.36%
2014-10-31$3.67M$3.28M+843.12%
2013-10-31$388.85k-$551.16k-58.63%
2012-10-31$940.01k-$63.18k-6.30%
2011-10-31$1.00M$272.52k+37.30%
2010-10-31$730.68k-$325.12k-30.79%
2009-10-31$1.06M-$1.01M-48.83%
2008-10-31$2.06M$1.58M+323.77%
2007-10-31$486.85k-$21.80k-4.29%
2006-10-31$508.65k$68.87k+15.66%
2005-10-31$439.79k-$54.68k-11.06%
2004-10-31$494.46k$250.24k+102.46%
2003-10-31$244.22k-$4.94M-95.29%
2002-10-31$5.19M$3.50M+206.77%
2001-10-31$1.69M$218.77k+14.86%
2000-10-31$1.47M$1.43M+3,040.13%
1999-10-31$46.88kN/AN/A
1998-10-31$0.00N/AN/A
1997-10-31$0.00N/AN/A
1996-10-31$0.00N/AN/A
1995-10-31$0.00N/AN/A

1 of 2

Anixa Biosciences Revenue FAQ

What was ANIX's revenue last quarter?

Anixa Biosciences (NASDAQ: ANIX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Anixa Biosciences's revenue was $0.00.

What was Anixa Biosciences's revenue in 2024?

Anixa Biosciences's annual revenue for the twelve months ending Oct 31, 2024 was $0.00, a 100% decrease year over year.

How much does Anixa Biosciences make in a day?

Based on Anixa Biosciences annual revenue for the past five years, ANIX makes an average of $395.62 per day.

What was Anixa Biosciences's annual revenue growth in the past year?

As of Q2 2025, Anixa Biosciences's revenue has grown -100% year over year. This is 611.06 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Anixa Biosciences's revenue in the past year totaled $0.00.

How much does Anixa Biosciences make in a year?

Anixa Biosciences's revenue by year for the past five years is:
  • Anixa Biosciences's revenue for the twelve months ending Oct 31, 2024 was $0.00, a 100% decrease year over year.
  • Anixa Biosciences's annual revenue for Oct 31, 2023 was $210.00 thousand, a Infinity% increase from 2022.
  • Anixa Biosciences's annual revenue for 2022 was $0.00, a 100% decrease from 2021.
  • Anixa Biosciences's annual revenue for 2021 was $512.00 thousand, a Infinity% increase from 2020.
  • Anixa Biosciences's annual revenue for 2020 was $0.00, a 100% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.